IDEXX Laboratories, Inc. Peer Comparison
Metric | Value | Ranking | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $36.4 Billion | 4/11 | TMO $203.4B |
DHR $149.0B |
A $38.4B |
IDXX $36.4B |
IQV $34.1B |
MTD $26.6B |
WAT $22.0B |
ILMN $15.9B |
ICLR $15.4B |
CRL $7.8B |
TWST $2.8B |
Gross Margin | 61% | 4/11 | A 100% |
ILMN 66% |
WAT 63% |
IDXX 61% |
MTD 61% |
DHR 59% |
TWST 45% |
TMO 43% |
IQV 35% |
CRL 35% |
ICLR 25% |
Profit Margin | 24% | 1/11 | IDXX 24% |
MTD 24% |
WAT 22% |
A 21% |
DHR 17% |
ILMN 17% |
TMO 16% |
IQV 11% |
ICLR 10% |
CRL 7% |
TWST -41% |
EBITDA margin | 21% | 5/11 | MTD 35% |
IQV 26% |
A 24% |
DHR 22% |
IDXX 21% |
ICLR 19% |
TMO 18% |
ILMN 16% |
CRL 12% |
WAT 6% |
TWST -43% |
Quarterly Revenue | $975.5 Million | 9/11 | TMO $11.4B |
DHR $6.5B |
IQV $4.0B |
ICLR $2.0B |
A $1.7B |
ILMN $1.1B |
MTD $1.0B |
CRL $1.0B |
IDXX $975.5M |
WAT $740.3M |
TWST $84.7M |
Quarterly Earnings | $232.8 Million | 6/11 | TMO $1.8B |
DHR $1.1B |
IQV $437.0M |
A $351.0M |
MTD $252.3M |
IDXX $232.8M |
ICLR $197.1M |
ILMN $187.0M |
WAT $161.5M |
CRL $69.7M |
TWST -$34.7M |
Quarterly Free Cash Flow | $192.0 Million | 6/11 | DHR $1.5B |
ICLR $370.1M |
ILMN $322.0M |
MTD $224.9M |
CRL $213.1M |
IDXX $192.0M |
WAT $179.0M |
A -$0 |
TMO -$0 |
IQV -$0 |
TWST -$0 |
Trailing 4 Quarters Revenue | $3.8 Billion | 9/11 | TMO $42.9B |
DHR $21.5B |
IQV $15.4B |
A $6.5B |
ICLR $6.2B |
ILMN $4.4B |
CRL $4.1B |
MTD $3.9B |
IDXX $3.8B |
WAT $2.9B |
TWST $313.0M |
Trailing 4 Quarters Earnings | $866.2 Million | 5/11 | TMO $11.4B |
DHR $6.5B |
IQV $4.0B |
ICLR $2.0B |
A $1.7B |
ILMN $1.1B |
MTD $1.0B |
CRL $1.0B |
IDXX $975.5M |
WAT $740.3M |
TWST $84.7M |
Quarterly Earnings Growth | 10% | 7/11 | ILMN 206% |
MTD 37% |
TWST 25% |
WAT 20% |
ICLR 20% |
TMO 12% |
IDXX 10% |
DHR 1% |
IQV -7% |
CRL -20% |
A -26% |
Annual Earnings Growth | -2% | 9/11 | A 60% |
ILMN 50% |
CRL 9% |
MTD 9% |
WAT 6% |
ICLR 4% |
TWST 4% |
IQV 0% |
IDXX -2% |
TMO -6% |
DHR -13% |
Quarterly Revenue Growth | 7% | 4/11 | DHR 73% |
TWST 27% |
MTD 12% |
IDXX 7% |
TMO 5% |
WAT 4% |
IQV 2% |
A 1% |
ICLR -1% |
ILMN -2% |
CRL -2% |
Annual Revenue Growth | 3% | 2/11 | TWST 21% |
IDXX 3% |
MTD 3% |
IQV 2% |
TMO 1% |
WAT -1% |
ILMN -2% |
A -3% |
CRL -3% |
DHR -12% |
ICLR -23% |
Cash On Hand | $308.6 Million | 8/11 | TMO $4.0B |
DHR $2.1B |
IQV $1.7B |
A $1.3B |
ILMN $1.1B |
ICLR $695.5M |
WAT $331.5M |
IDXX $308.6M |
TWST $226.3M |
CRL $210.2M |
MTD $59.4M |
Short Term Debt | $349.1 Million | 5/11 | TMO $2.2B |
IQV $1.1B |
DHR $505.0M |
ILMN $499.0M |
IDXX $349.1M |
MTD $182.6M |
A $45.0M |
ICLR $29.8M |
WAT $25.3M |
TWST $14.8M |
CRL $3.2M |
Long Term Debt | $524.8 Million | 8/11 | TMO $29.1B |
DHR $15.5B |
ICLR $3.4B |
A $3.3B |
CRL $2.8B |
ILMN $2.0B |
MTD $1.8B |
IDXX $524.8M |
IQV $173.0M |
TWST $70.2M |
WAT $0 |
PE | 42.02 | 1/11 | IDXX 42.02 |
DHR 38.22 |
WAT 35.26 |
TMO 32.11 |
MTD 30.82 |
A 29.81 |
ICLR 28.93 |
IQV 24.81 |
CRL 18.77 |
ILMN -1.00 |
TWST -1.00 |
PS | 9.47 | 1/11 | IDXX 9.47 |
TWST 9.07 |
WAT 7.56 |
DHR 6.94 |
MTD 6.87 |
A 5.90 |
TMO 4.74 |
ILMN 3.63 |
ICLR 2.46 |
IQV 2.21 |
CRL 1.91 |
PB | 22.50 | 1/11 | IDXX 22.50 |
WAT 13.69 |
A 6.51 |
TWST 6.01 |
ILMN 5.85 |
IQV 5.61 |
TMO 4.11 |
DHR 3.01 |
CRL 2.03 |
ICLR 1.57 |
MTD 0.00 |
PC | 117.94 | 2/11 | MTD 448.16 |
IDXX 117.94 |
DHR 71.71 |
WAT 66.23 |
TMO 50.74 |
CRL 36.98 |
A 28.91 |
ICLR 22.10 |
IQV 20.01 |
ILMN 14.09 |
TWST 12.54 |
Liabilities to Equity | 1.07 | 5/11 | IQV 3.43 |
WAT 1.81 |
ILMN 1.32 |
CRL 1.10 |
IDXX 1.07 |
MTD 1.04 |
A 1.01 |
TMO 0.96 |
ICLR 0.76 |
DHR 0.57 |
TWST 0.30 |
ROA | 0.26 | 2/11 | MTD 27% | IDXX 26% | WAT 14% | A 11% | TMO 7% | DHR 5% | IQV 5% | CRL 5% | ICLR 3% | ILMN -19% | TWST -34% |
ROE | 0.54 | 1/11 | IDXX 54% |
WAT 39% |
MTD 27% |
IQV 23% |
A 22% |
TMO 13% |
CRL 11% |
DHR 8% |
ICLR 5% |
TWST -44% |
ILMN -45% |
Current Ratio | 1.93 | 6/11 | TWST 4.34 |
DHR 2.77 |
ICLR 2.31 |
TMO 2.04 |
A 1.99 |
IDXX 1.93 |
CRL 1.92 |
ILMN 1.76 |
WAT 1.55 |
IQV 1.29 |
MTD 0.96 |
Quick Ratio | 0.18 | 4/11 | IDXX 42.02 |
DHR 38.22 |
WAT 35.26 |
TMO 32.11 |
MTD 30.82 |
A 29.81 |
ICLR 28.93 |
IQV 24.81 |
CRL 18.77 |
ILMN -1.00 |
TWST -1.00 |
Long Term Debt to Equity | 0.32 | 7/11 | ILMN} 0.75 |
CRL} 0.73 |
TMO} 0.59 |
A} 0.57 |
MTD} 0.57 |
ICLR} 0.35 |
IDXX} 0.32 |
DHR} 0.31 |
TWST} 0.15 |
IQV} 0.03 |
WAT} 0.00 |
Debt to Equity | 0.54 | 6/11 | ILMN 0.94 |
CRL 0.73 |
TMO 0.63 |
MTD 0.62 |
A 0.57 |
IDXX 0.54 |
ICLR 0.35 |
DHR 0.32 |
IQV 0.22 |
TWST 0.18 |
WAT 0.02 |
Burn Rate | -2.48 | 6/11 | ILMN 57.77 |
TWST 5.50 |
CRL 5.06 |
MTD -0.45 |
WAT -2.14 |
IDXX -2.48 |
DHR -6.12 |
A -6.45 |
IQV -11.83 |
ICLR -12.98 |
TMO -35.15 |
Cash to Cap | 0.01 | 9/11 | TWST 0.08 |
ILMN 0.07 |
IQV 0.05 |
ICLR 0.05 |
A 0.03 |
CRL 0.03 |
TMO 0.02 |
WAT 0.02 |
IDXX 0.01 |
DHR 0.01 |
MTD 0.00 |
CCR | 0.82 | 7/11 | CRL 3.06 |
ICLR 1.88 |
ILMN 1.72 |
DHR 1.38 |
WAT 1.11 |
MTD 0.89 |
IDXX 0.82 |
A |
TMO |
IQV |
TWST |
EV to EBITDA | 178.07 | 2/11 | WAT} 517.33 |
IDXX} 178.07 |
TMO} 114.43 |
DHR} 114.34 |
A} 99.22 |
ILMN} 98.82 |
CRL} 87.91 |
MTD} 78.62 |
ICLR} 46.28 |
IQV} 32.92 |
TWST} -74.84 |
EV to Revenue | 9.61 | 1/11 | IDXX 9.61 |
TWST 8.62 |
DHR 7.59 |
WAT 7.45 |
MTD 7.37 |
A 6.22 |
TMO 5.38 |
ILMN 3.96 |
ICLR 2.90 |
CRL 2.54 |
IQV 2.19 |